N-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-[[1-(3,4-dimethoxyphenyl)-5-tetrazolyl]thio]acetamide (Q27209862)

SMR000003535 (English)

11 October 2016

chemical formula

C₁₉H₁₉N₅O₅S

1 reference

SMR000003535 (English)

11 October 2016

canonical SMILES

COC1=C(C=C(C=C1)N2C(=NN=N2)SCC(=O)NC3=CC4=C(C=C3)OCCO4)OC

1 reference

SMR000003535 (English)

InChI=1S/C19H19N5O5S/c1-26-14-6-4-13(10-16(14)27-2)24-19(21-22-23-24)30-11-18(25)20-12-3-5-15-17(9-12)29-8-7-28-15/h3-6,9-10H,7-8,11H2,1-2H3,(H,20,25)

11 October 2016

Identifiers

InChI

1 reference

SMR000003535 (English)

WRRGFFYTLWGXFT-UHFFFAOYSA-N

11 October 2016

InChIKey

2 references

SMR000003535 (English)

11 October 2016

stated in

ChEBI release 2020-09-01

1 reference

N-(2,3-Dihydro-1,4-benzodioxin-6-yl)-2-{[1-(3,4-dimethoxyphenyl)-1H-tetrazol-5-yl]sulfanyl}acetamide (English)

11 October 2016

1 reference

SMR000003535 (English)

11 October 2016

ChEBI ID

121326

mapping relation type

1 reference

N-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-[[1-(3,4-dimethoxyphenyl)-5-tetrazolyl]thio]acetamide (English)

11 October 2016

1 reference